Nature Immunology corrects source data in IGHG1 variant paper after figure-level errors
A correction has been issued for a 2024 Nature Immunology paper on an IGHG1 variant linked to polarized prevalence and enhanced IgG1 antibody responses against life-threatening organisms. The amendment does not change the paper’s central topic; it fixes the evidentiary scaffolding around several figures and their source data. In biomedical publishing, those details are not clerical afterthoughts. They are the record that allows readers, reviewers, and other scientists to trace a displayed result back to the exact dataset used to generate it.
The corrected article now reflects labeling and organizational errors in the Source Data for Figs. 2j and 4f, g, k. Source Data not used in the published article had been included inadvertently. In addition, Source Data for Figs. 4d, h, l and Extended Data Fig. 1d, i, along with their associated figure panels, had been built from incorrect datasets. Those panels have now been updated in the HTML and PDF versions of the article, and the original and corrected figures are available as Supplementary Information accompanying the amendment.
A single incorrect dataset can distort the interpretation of a mechanistic paper even when the overall hypothesis remains intact.
The correction is narrow in scope, but the implications reach beyond layout and file naming. Studies of antibody genetics depend on close alignment between genotype, phenotype, and the visual presentation of those relationships. When source data are mislabeled or organized incorrectly, downstream readers may misread the direction, strength, or reproducibility of a finding even if the main text remains unchanged. In an area such as immunoglobulin variation, where investigators are trying to connect sequence-level differences to functional antibody output, fidelity at the figure level is essential.
The article itself centers on an IGHG1 variant and its association with enhanced IgG1 antibody responses against severe pathogens. That kind of work sits at the interface of human genetics, humoral immunity, and infectious disease biology. IgG1 is a dominant effector subclass in antiviral and antibacterial immunity, and variation in the constant region can shape how antibodies behave in circulation and at the immune synapse. For that reason, a paper in this space is read not only for its broad claim, but for the precise evidence embedded in each panel, axis label, and dataset annotation.
Corrections of this type are part of the normal self-correcting machinery of scientific publication, but they are still consequential. Source data files often function as the most direct bridge between a manuscript’s polished figures and the underlying experimental output. When those files contain mislabeled entries, extraneous data, or the wrong dataset, the risk is not merely cosmetic. It complicates independent verification, secondary analysis, and any effort to compare the published result with later work from the same laboratory or from other groups.
Here, the editorial record makes clear that the affected material has been replaced in the article’s online versions. The availability of original and corrected figures in Supplementary Information also creates a transparent audit trail. That kind of transparency matters because corrections can be read in two very different ways: as a sign of weakness, or as evidence that the publication system is capable of identifying and repairing errors in the scientific record. In practice, the second interpretation is the more useful one. Biology is messy, file management is fallible, and complex multi-figure studies move through many hands before they are published.
For readers focused on antibody biology, the main clinical and translational question remains how much the corrected source files alter confidence in the specific data displays rather than the overall premise of the work. This correction notice does not describe a retraction, does not announce a change to the article’s title or framing, and does not introduce any new experimental claim. Instead, it narrows attention to the integrity of several figure-linked datasets and the need to ensure that visual evidence matches the correct underlying records.
Those distinctions are important in immunology, where small graphical differences can influence how a variant is interpreted in relation to protective immunity. A mislabeled panel can send a reader toward the wrong dataset, especially when a paper contains multiple figures, extended data panels, and layered comparisons across cohorts or assays. Clean source data reduce that risk. They also preserve the value of the work for investigators who may want to build on the same variant, assay system, or analytical framework.
The corrected publication now stands as both a scientific report and a record of editorial repair. The central subject remains an IGHG1 variant and its relationship to IgG1 responses against dangerous organisms, but the publication history now includes a formal acknowledgment that some source data and figure panels were assembled incorrectly in the initial version. In mechanistic immunology, where the details often carry the main weight of the argument, that kind of correction is not peripheral. It is part of the evidence chain itself.